Impact of ERCC1 gene polymorphisms on response to cisplatin based therapy in oral squamous cell carcinoma (OSCC) patients

Impact of ERCC1 gene polymorphisms on response to cisplatin based therapy in oral squamous cell carcinoma (OSCC) patients

Background and Objectives: Cisplatin is one of the major drugs that used in the treatment of oral cancer.Excision repair cross-complementation group 1 (ERCC1) is a key DNA repair gene in the nucleotide excision repair pathway which is activated in the repair of intra- and interstrand DNA crosslink c...

Full description

Bibliographic Details
Main Authors: M L Avinash Tejasvi, G Maragathavalli, Uday Kumar Putcha, M Ramakrishna, R Vijayaraghavan, C K Anulekha Avinash
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2020-01-01
Series:Indian Journal of Pathology and Microbiology
Subjects:
cisplatin
ercc
expression
oral squamous cell carcinoma
pcr-rflp
polymorphism
Online Access:http://www.ijpmonline.org/article.asp?issn=0377-4929;year=2020;volume=63;issue=4;spage=538;epage=543;aulast=Avinash

Internet

http://www.ijpmonline.org/article.asp?issn=0377-4929;year=2020;volume=63;issue=4;spage=538;epage=543;aulast=Avinash

Similar Items